Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome.


Journal

Platelets
ISSN: 1369-1635
Titre abrégé: Platelets
Pays: England
ID NLM: 9208117

Informations de publication

Date de publication:
2019
Historique:
pubmed: 14 2 2019
medline: 18 4 2019
entrez: 14 2 2019
Statut: ppublish

Résumé

Higher aspirin doses may be inferior in ticagrelor-treated acute coronary syndrome (ACS) patients and reducing bleeding risk whilst maintaining antithrombotic benefits could improve outcomes. We characterized the pharmacodynamics of a novel dual-antiplatelet-therapy regimen consisting of very-low-dose twice-daily (BD) aspirin with standard-dose ticagrelor. A total of 20 ticagrelor-treated ACS patients entered a randomized crossover to take aspirin 20 mg BD (12-hourly) during one 14-day period and 75 mg once-daily (OD) in the other. After 14 days of treatment, serum thromboxane (TX)B

Identifiants

pubmed: 30759035
doi: 10.1080/09537104.2019.1572880
pmc: PMC6425913
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0
Aspirin R16CO5Y76E

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-157

Subventions

Organisme : British Heart Foundation
ID : FS/15/82/31824
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/18/49/33752
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17176
Pays : United Kingdom

Références

Clin Cardiol. 2000 Sep;23(9):697-700
pubmed: 11016021
Therapie. 2001 Nov-Dec;56(6):669-74
pubmed: 11878089
Stroke. 1992 Oct;23(10):1400-3
pubmed: 1412574
Lancet. 2004 Dec 4-10;364(9450):2021-9
pubmed: 15582059
Thromb Res. 2005;116(6):509-17
pubmed: 16181986
Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2783-9
pubmed: 17932316
Arterioscler Thromb Vasc Biol. 2009 May;29(5):712-7
pubmed: 19286636
N Engl J Med. 2009 Sep 10;361(11):1045-57
pubmed: 19717846
Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):863-7
pubmed: 20233808
Int J Hematol. 2010 Sep;92(2):296-301
pubmed: 20725815
Thromb Haemost. 2011 Feb;105(2):336-44
pubmed: 21136023
J Thromb Haemost. 2011 Mar;9(3):552-61
pubmed: 21143373
Circulation. 2011 Aug 2;124(5):544-54
pubmed: 21709065
Thromb Haemost. 2011 Sep;106(3):491-9
pubmed: 21800009
Blood. 2012 Apr 12;119(15):3595-603
pubmed: 22234683
J Thromb Haemost. 2012 Jul;10(7):1220-30
pubmed: 22471290
Eur Heart J. 2012 Oct;33(20):2569-619
pubmed: 22922416
Am Heart J. 2012 Oct;164(4):600-606.e1
pubmed: 23067920
Platelets. 2013;24(8):615-24
pubmed: 23249161
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140
pubmed: 23256914
PLoS One. 2013 Aug 19;8(8):e71150
pubmed: 23976993
Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15782-7
pubmed: 24003163
Platelets. 2014;25(6):416-22
pubmed: 24111601
Thromb Haemost. 2014 Jul 3;112(1):118-27
pubmed: 24671522
Diabetologia. 2014 Aug;57(8):1737-41
pubmed: 24838681
PLoS One. 2014 Jun 02;9(6):e98165
pubmed: 24887395
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2078-85
pubmed: 25012137
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
J Am Coll Cardiol. 2014 Nov 18-25;64(20):2071-82
pubmed: 25193393
EuroIntervention. 2015 Nov;11(7):737-45
pubmed: 25254357
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228
pubmed: 25260718
J Thromb Haemost. 2015 Mar;13(3):448-56
pubmed: 25546465
N Engl J Med. 2015 May 7;372(19):1791-800
pubmed: 25773268
Arterioscler Thromb Vasc Biol. 2015 Aug;35(8):1805-14
pubmed: 26044583
Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2122-33
pubmed: 26272940
Eur Heart J. 2016 Jan 14;37(3):267-315
pubmed: 26320110
Eur Heart J. 2016 Nov 21;37(44):3347-3356
pubmed: 26516174
Thromb Haemost. 2016 Mar;115(3):622-31
pubmed: 26633836
J Am Coll Cardiol. 2016 Mar 15;67(10):1145-1154
pubmed: 26965534
J Am Coll Cardiol. 2016 Jun 14;67(23):2732-2740
pubmed: 27046160
J Am Coll Cardiol. 2016 Jun 14;67(23):2719-2728
pubmed: 27046162
JAMA Cardiol. 2016 Jul 01;1(4):425-32
pubmed: 27438319
Biochim Biophys Acta. 1989 Jul 21;992(1):66-70
pubmed: 2752040
J Am Coll Cardiol. 2017 Feb 14;69(6):613-615
pubmed: 28089179
Clin Pharmacol Ther. 2017 Nov;102(5):849-858
pubmed: 28379623
Eur J Prev Cardiol. 2017 Jun;24(9):962-970
pubmed: 28436725
BMJ. 2017 May 9;357:j1909
pubmed: 28487435
Eur Heart J. 2018 Apr 1;39(13):1078-1085
pubmed: 29390064
J Am Coll Cardiol. 2018 Feb 6;71(5):489-496
pubmed: 29406853
Platelets. 2019;30(3):322-328
pubmed: 29442537
Blood Cancer J. 2018 Jun 1;8(6):49
pubmed: 29880847
Nat Rev Cardiol. 2018 Aug;15(8):480-496
pubmed: 29973709
Lancet. 2018 Sep 15;392(10151):940-949
pubmed: 30166073
J Clin Invest. 1983 Mar;71(3):676-88
pubmed: 6338043
N Engl J Med. 1983 Apr 7;308(14):800-5
pubmed: 6339916
J Pharmacol Exp Ther. 1983 Jul;226(1):78-87
pubmed: 6345756
Thromb Haemost. 1983 Oct 31;50(3):669-70
pubmed: 6417815
J Clin Invest. 1982 Jun;69(6):1366-72
pubmed: 7045161
Thromb Res. 1980 Feb 1-15;17(3-4):317-27
pubmed: 7368167
J Neurol Sci. 1996 Nov;143(1-2):1-13
pubmed: 8981292
Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2309-15
pubmed: 9409197

Auteurs

William A E Parker (WAE)

a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.
b Department of Cardiology , Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK.

Rachel C Orme (RC)

a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.
b Department of Cardiology , Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK.

Jessica Hanson (J)

a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.

Hannah M Stokes (HM)

a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.

Claire M Bridge (CM)

a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.

Patricia A Shaw (PA)

a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.

Wael Sumaya (W)

a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.
b Department of Cardiology , Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK.

Kirstie Thorneycroft (K)

a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.

Giovanna Petrucci (G)

c Institute of Pharmacology , Catholic University School of Medicine , Rome , Italy.

Benedetta Porro (B)

d Centro Cardiologico Monzino , Istituto di Ricovero e Cura a Carattere Scientifico Cardiologico Monzino , Milan , Italy.

Heather M Judge (HM)

a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.

Ramzi A Ajjan (RA)

e Leeds Institute of Cardiovascular and Metabolic Medicine , University of Leeds , Leeds , UK.

Bianca Rocca (B)

c Institute of Pharmacology , Catholic University School of Medicine , Rome , Italy.

Robert F Storey (RF)

a Department of Infection, Immunity and Cardiovascular Disease , University of Sheffield , Sheffield , United Kingdom.
b Department of Cardiology , Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH